XML 122 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Borrowings (Tables)
12 Months Ended
Dec. 31, 2019
Debt Instrument, Redemption [Line Items]  
Schedule of Match Funded Liabilities
Match Funded Liabilities

 
 
 
 
 
 
 
December 31, 2019
 
December 31, 2018
Borrowing Type
 
Maturity (1)
 
Amorti-zation Date (1)
 
Available Borrowing Capacity (2)
 
Weighted Average Interest Rate (3)
 
Balance
 
Weighted Average Interest Rate (3)
 
Balance
Advance Financing Facilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Advance Receivables Backed Notes - Series 2015-VF5 (4)
 
Dec. 2049
 
Dec. 2020
 
$
9,445

 
3.36

 
$
190,555

 
4.06

 
$
216,559

Advance Receivables Backed Notes - Series 2016-T2 (5)
 
Aug. 2049
 
Aug. 2019
 

 

 

 
2.99

 
235,000

Advance Receivables Backed Notes, Series 2018-T1 (5)
 
Aug. 2049
 
Aug. 2019
 

 

 

 
3.50

 
150,000

Advance Receivables Backed Notes, Series 2018-T2 (5)
 
Aug. 2050
 
Aug. 2020
 

 

 

 
3.81

 
150,000

Advance Receivables Backed Notes, Series 2019-T1 (5)
 
Aug. 2050
 
Aug. 2020
 

 
2.62

 
185,000

 

 

Advance Receivables Backed Notes, Series 2019-T2 (5)
 
Aug. 2051
 
Aug. 2021
 

 
2.53

 
285,000

 

 

Total Ocwen Master Advance Receivables Trust (OMART)
 
 
 
 
 
9,445

 
2.79

 
660,555

 
3.56

 
751,559

Ocwen Freddie Advance Funding (OFAF) - Advance Receivables Backed Notes, Series 2015-VF1 (6)
 
Jun. 2050
 
Jun. 2020
 
41,446

 
3.53

 
18,554

 
5.03

 
26,725

 
 
 
 
 
 
$
50,891

 
2.81
%
 
$
679,109

 
3.61
%
 
$
778,284

(1)
The amortization date of our facilities is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the date on which all outstanding balances must be repaid. In all of our advance facilities, there are multiple notes outstanding. For each note, after the amortization date, all collections that represent the repayment of advances pledged to the facility must be applied ratably to each outstanding amortizing note to reduce the balance and as such the collection of advances allocated to the amortizing note may not be used to fund new advances.
(2)
Borrowing capacity under the OMART and OFAF facilities is available to us provided that we have sufficient eligible collateral to pledge. At December 31, 2019, none of the available borrowing capacity of our advance financing notes could be used based on the amount of eligible collateral.
(3)
1ML was 1.76% and 2.50% at December 31, 2019 and 2018, respectively.
(4)
On December 12, 2019, we renewed this facility through December 11, 2020 and borrowing capacity was reduced from $225.0 million to $200.0 million, with interest computed based on the lender’s cost of funds plus a margin. At December 31, 2019, the weighted average interest margin was 136 bps.
(5)
On August 14, 2019, we issued two fixed-rate term notes of $185.0 million (Series 2019 T-1) and $285.0 million (Series 2019-T2) with amortization dates of August 17, 2020 and August 16, 2021, respectively, for a total combined borrowing capacity of $470.0 million. The weighted average rate of the notes at December 31, 2019 is 2.57% with rates on the individual classes of notes ranging from 2.42% to 4.44%. The Series 2016-T2, 2018-T1 and 2018-T2 fixed-rate term notes were all redeemed on August 15, 2019.
(6)
On June 6, 2019, we renewed this facility through June 5, 2020 and borrowing capacity was reduced from $65.0 million to $60.0 million with interest computed based on the lender’s cost of funds plus a margin. At December 31, 2019, the weighted average interest margin was 157 bps.
Schedule of Financing Liabilities
Financing Liabilities
 
 
 
 
 
 
 
Outstanding Balance at December 31,
Borrowing Type
 
Collateral
 
Interest Rate
 
Maturity
 
2019
 
2018
HMBS-Related Borrowings, at fair value (1)
 
Loans held for investment
 
1ML + 260 bps
 
(1)
 
$
6,063,435

 
$
5,380,448

 
 
 
 
 
 
 
 
 
 
 
Other Financing Liabilities
 
 
 
 
 
 
 
 
 
 
MSRs pledged (Rights to MSRs), at fair value:
 
 
 
 
 
 
 
 
 
 
Original Rights to MSRs Agreements
 
MSRs
 
(2)
 
(2)
 
603,046

 
436,511

2017 Agreements and New RMSR Agreements
 
MSRs
 
(3)
 
(3)
 
35,445

 
138,854

PMC MSR Agreements
 
MSRs
 
(4)
 
(4)
 
312,102

 
457,491

 
 
 
 
 
 
 
 
950,593

 
1,032,856

Financing liability - Owed to securitization investors, at fair value:
 
 
 
 
 
 
 
 
 
 
IndyMac Mortgage Loan Trust (INDX 2004-AR11) (5)
 
Loans held for investment
 
(5)
 
(5)
 
9,794

 
11,012

Residential Asset Securitization Trust 2003-A11 (RAST 2003-A11) (5)
 
Loans held for investment
 
(5)
 
(5)
 
12,208

 
13,803

 
 
 
 
 
 
 
 
22,002

 
24,815

Advances pledged (6)
 
Advances on loans
 
(6)
 
 
 

 
4,419

Total Other financing liabilities
 
 
 
 
 
 
 
972,595

 
1,062,090

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
7,036,030

 
$
6,442,538

(1)
Represents amounts due to the holders of beneficial interests in Ginnie Mae guaranteed HMBS which did not qualify for sale accounting treatment of HECM loans. Under this accounting treatment, the HECM loans securitized with Ginnie Mae remain on our consolidated balance sheet and the proceeds from the sale are recognized as a secured liability. The beneficial interests have no maturity dates, and the borrowings mature as the related loans are repaid. We elected to record the HMBS-related borrowings at fair value consistent with the related HECM loans. Changes in fair value are reported within Reverse mortgage revenue, net.
(2)
This pledged MSR liability is recognized due to the accounting treatment of MSR sale transactions with NRZ which did not qualify as sales for accounting purposes. Under this accounting treatment, the MSRs transferred to NRZ remain on the consolidated balance sheet and the proceeds from the sale are recognized as a secured liability. This financing liability has no contractual maturity or repayment schedule. We elected to record the liability at fair value consistent with the related MSRs. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows underlying the related MSRs. Changes in fair value are reported within Pledged MSR liability expense, and are offset by corresponding changes in fair value of the MSR pledged to NRZ within MSR valuation adjustments, net.
(3)
This financing liability arose in connection with lump sum payments of $54.6 million received upon transfer of legal title of the MSRs related to the Rights to MSRs transactions to NRZ in September 2017. In connection with the execution of the New RMSR Agreements in January 2018, we received a lump sum payment of $279.6 million as compensation for foregoing certain payments under the Original Rights to MSRs Agreements. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows. The expected maturity of the liability is April 30, 2020, the date through which we were scheduled to be the servicer on loans underlying the Rights to MSRs per the Original Rights to MSRs Agreements.
(4)
Represents a liability for sales of MSRs to NRZ which did not qualify for sale accounting treatment and are accounted for as a secured borrowing which we assumed in connection with the acquisition of PHH. Under this accounting treatment, the MSRs transferred to NRZ remain on the consolidated balance sheet and the proceeds from the sale are recognized as a secured liability. We elected to record the liability at fair value consistent with the related MSRs.
(5)
Consists of securitization debt certificates due to third parties that represent beneficial interests in trusts that we include in our consolidated financial statements, as more fully described in Note 4 — Securitizations and Variable Interest Entities. The holders of these certificates have no recourse against the assets of Ocwen. The certificates in the INDX 2004-AR11 Trust pay interest based on variable rates which are generally based on weighted average net mortgage rates and which range between 3.39% and 3.85% at December 31, 2019. The certificates in the RAST 2003-A11 Trust pay interest based on fixed rates ranging between 4.25% and 5.75% and a variable rate based on 1ML plus 0.45%. The maturity of the certificates occurs upon maturity of the loans held by the trust. The remaining loans in the INDX 2004-AR11 Trust and RAST 2003-A11 Trust have maturity dates extending through November 2034 and October 2033, respectively.
(6)
Certain sales of advances did not qualify for sales accounting treatment and were accounted for as a financing. This financing liability has no contractual maturity. The effective interest rate is based on 1ML plus a margin of 450 bps.
Schedule of Other Secured Borrowings
Other Secured Borrowings
 
 
 
 
 
 
 
 
 
Outstanding Balance at December 31,
Borrowing Type
 
Collateral
 
Interest Rate
 
Termination / Maturity
 
Available Borrowing Capacity (1)
 
2019
 
2018
SSTL (2)
 
(2)
 
1-Month Euro-dollar rate + 500 bps with a Eurodollar floor of 100 bps (2)
 
Dec. 2020
 
$

 
$
326,066

 
$
231,500

 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loan warehouse facilities
 
 
 
 
 
 
 
 
 
 
 
 
Master repurchase agreement (3)
 
Loans held for sale (LHFS)
 
1ML + 195 - 300 bps
 
Sep. 2020
 
8,427

 
91,573

 
74,693

Participation agreements (4)
 
LHFS
 
N/A
 
Jul. 2019
 

 

 
42,331

Mortgage warehouse agreement (5)
 
LHFS (reverse mortgages)
 
1ML + 250 bps; 1ML floor of 350 bps
 
Aug. 2020
 

 
72,443

 
8,009

Master repurchase agreement (6)
 
LHFS (forward and reverse mortgages)
 
1ML + 225 bps forward; 1ML + 275 bps reverse
 
Dec. 2020
 
60,773

 
139,227

 
30,680

Master repurchase agreement (7)
 
LHFS (reverse mortgages)
 
Prime - 0.25% (3.75% floor)
 
Jan. 2020
 

 
898

 

Master repurchase agreement (8)
 
N/A
 
1ML + 170 bps
 
N/A
 

 

 

Participation agreement (9)
 
LHFS
 
(9)
 
Feb. 2020
 

 
17,304

 

Mortgage warehouse agreement (10)
 
LHFS (reverse mortgages)
 
1ML + 350 bps; 1ML floor of 525 bps
 
Dec. 2020
 
39,220

 
10,780

 

 
 
 
 
 
 
 
 
108,420

 
332,225

 
155,713

 
 
 
 
 
 
 
 
 
 
 
 
 
Other Secured Borrowings
 
 
 
 
 
 
 
 
 
Outstanding Balance at December 31,
Borrowing Type
 
Collateral
 
Interest Rate
 
Termination / Maturity
 
Available Borrowing Capacity (1)
 
2019
 
2018
Agency MSR financing facility (11)
 
MSRs
 
1ML + 300 bps
 
Jun. 2020
 
152,294

 
147,706

 

Ginnie Mae MSR financing facility (12)
 
MSRs
 
1ML + 395 bps
 
Nov. 2021
 
27,680

 
72,320

 

Ocwen Excess Spread-Collateralized Notes, Series 2019-PLS1 (13)
 
MSRs
 
5.07%
 
Nov. 2024
 

 
94,395

 

Ocwen Asset Servicing Income Series Notes, Series 2014-1 (14)
 
MSRs
 
(14)
 
Feb. 2028
 

 
57,594

 
65,523

 
 
 
 
 
 
 
 
179,974

 
372,015

 
65,523

 
 
 
 
 
 
 
 
$
288,394

 
1,030,306

 
452,736

Unamortized debt issuance costs - SSTL and PLS Notes
 
(3,381
)
 
(3,098
)
Discount - SSTL
 
(1,134
)
 
(1,577
)
 
 
 
 
 
 
 
 


 
$
1,025,791

 
$
448,061

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
4.74
%
 
4.70
%
(1)
Available borrowing capacity for our mortgage loan warehouse facilities does not consider the amount of the facility that the lender has extended on an uncommitted basis. Of the borrowing capacity extended on a committed basis, none of the available borrowing capacity could be used at December 31, 2019 based on the amount of eligible collateral that could be pledged.
(2)
On March 18, 2019, we entered into a Joinder and Amendment Agreement which amends the existing Amended and Restated SSTL Facility Agreement dated December 5, 2016 to provide an additional term loan of $120.0 million subject to the same maturity, interest rate and other material terms of existing borrowings under the SSTL. Effective with this amendment, the quarterly principal payment increased from $4.2 million to $6.4 million beginning March 31, 2019. See information regarding collateral in the table below.
Borrowings bear interest, at the election of Ocwen, at a rate per annum equal to either (a) the base rate (the greatest of (i) the prime rate in effect on such day, (ii) the federal funds rate in effect on such day plus 0.50% and (iii) 1ML, plus a margin of 4.00% and subject to a base rate floor of 2.00% or (b) 1ML, plus a margin of 5.00% and subject to a 1ML floor of 1.00%. To date we have elected option (b) to determine the interest rate.
On January 27, 2020, we prepaid $126.1 million of the outstanding balance at December 31, 2019 and executed an additional amendment to the SSTL which reduced the maximum borrowing capacity to $200.0 million, extended the maturity date to May 15, 2022, reduced the quarterly principal payment to $5.0 million and modified the interest rate. See Note 28 — Subsequent Events for additional information.
(3)
The maximum borrowing under this agreement is $175.0 million, of which $100.0 million is available on a committed basis and the remainder is available at the discretion of the lender. On September 27, 2019, we renewed this facility through September 25, 2020.
(4)
Effective with the mergers of Homeward Residential, Inc. (Homeward) into PMC in February 2019 and Ocwen Loan Servicing, LLC (OLS) into PMC in June 2019, the participation agreements with total uncommitted borrowing capacity of $250.0 million were terminated.
(5)
Under this participation agreement, the lender provides financing for $100.0 million on an uncommitted basis. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. On August 13, 2019, we renewed this facility through August 14, 2020.
(6)
On December 6, 2019, we renewed this facility through December 5, 2020. The maximum borrowing under this agreement is $250.0 million, of which $200.0 million is available on a committed basis and the remainder is available on an uncommitted basis. The agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing.
(7)
Under this agreement, the lender provides financing for up to $50.0 million on an uncommitted basis. This facility expired on January 22, 2020 and was not renewed.
(8)
This agreement was originally entered into by PHH and subsequently assumed by Ocwen in connection with its acquisition of PHH. The lender provides financing for up to $200.0 million at the discretion of the lender. The agreement has no stated maturity date.
(9)
We entered into a master participation agreement on February 4, 2019 under which the lender will provide $300.0 million of borrowing capacity to PMC on an uncommitted basis. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans less 25 bps while the loans are financed under the participation agreement. On January 27, 2020, we renewed this facility through April 3, 2020.
(10)
On December 26, 2019, PMC entered into a warehouse facility. Under this agreement, the lender provides financing for up to $50.0 million on a committed basis. The lender earns the stated interest rate of 1ML plus a margin of 350 bps .
(11)
On July 1, 2019, PMC entered into a financing facility that is secured by certain Fannie Mae and Freddie Mac MSRs. In connection with this facility, PMC entered into repurchase agreements pursuant to which PMC sold trust certificates representing certain indirect economic interests in the MSRs and agreed to repurchase such trust certificates at a future date at the repurchase price set forth in the repurchase agreements. PMC’s obligations under this facility are secured by a lien on the related MSRs. Ocwen guarantees the obligations of PMC under this facility. The maximum amount which we may borrow pursuant to the repurchase agreements is $300.0 million on a committed basis. The lender earns the stated interest rate of 1ML plus a margin of 300 bps. See Note 4 — Securitizations and Variable Interest Entities for additional information.
(12)
On November 26, 2019, PMC entered into a financing facility that is secured by certain Ginnie Mae MSRs. In connection with the facility, PMC entered into a repurchase agreement pursuant to which PMC has sold a participation certificate representing certain economic interests in the Ginnie Mae MSRs and has agreed to repurchase such participation certificate at a future date at the repurchase price set forth in the repurchase agreement. PMC’s obligations under the facility are secured by a lien on the related Ginnie Mae MSRs. Ocwen guarantees the obligations of PMC under the facility. The maximum amount available to be borrowed pursuant to the facility is $27.7 million on a committed basis. The lender earns the stated interest rate of 1ML plus a margin of 395 bps.
(13)
On November 26, 2019, PMC issued the PLS Notes secured by certain of PMC’s MSRs (PLS MSRs) pursuant to a credit agreement. PLS Issuer’s obligations under the facility are secured by a lien on the related PLS MSRs. Ocwen guarantees the obligations of PLS Issuer under the facility. The Class A PLS Notes issued pursuant to the credit agreement have an initial principal amount of $100.0 million and amortize in accordance with a pre-determined schedule subject to modification under certain events. The notes have a stated coupon rate of 5.07%. See Note 4 — Securitizations and Variable Interest Entities for additional information.
(14)
OASIS noteholders are entitled to receive a monthly payment equal to the sum of: (a) 21 basis points of the UPB of the reference pool of Freddie Mac mortgages; (b) any termination payment amounts; (c) any excess refinance amounts; and (d) the note redemption amounts, each as defined in the indenture supplement for the notes. Monthly amortization of the liability is estimated using the proportion of monthly projected service fees on the underlying MSRs as a percentage of lifetime projected fees, adjusted for the term of the notes.
Schedule of Senior Notes
Senior Notes

 
 
 
 
Outstanding Balance at December 31,
 
Interest Rate
 
Maturity
 
2019
 
2018
Senior unsecured notes:
 
 
 
 
 
 
 
PHH (1) (2)
7.375%
 
Sep. 2019
 
$

 
$
97,521

PHH (2)
6.375%
 
Aug. 2021
 
21,543

 
21,543

 
 
 
 
 
21,543

 
119,064

 
 
 
 
 
 
 
 
Senior secured notes (3)
8.375%
 
Nov. 2022
 
291,509

 
330,878

 
 
 
 
 
313,052

 
449,942

Unamortized debt issuance costs
 
(1,470
)
 
(2,075
)
Fair value adjustments (2)
 
 
 
 
(497
)
 
860

 
 
 
 
 
$
311,085

 
$
448,727

(1)
On September 2, 2019, we redeemed all of the Senior unsecured notes due in September 2019, at a redemption price of 100.0% of the outstanding principal balance plus accrued and unpaid interest.
(2)
These notes were originally issued by PHH and subsequently assumed by Ocwen in connection with its acquisition of PHH. We recorded the notes at their respective fair values on the date of acquisition, and we are amortizing the resulting fair value purchase accounting adjustments over the remaining term of the notes. We have the option to redeem the notes due in August 2021, in whole or in part, on or after January 1, 2019 at a redemption price equal to 100.0% of the principal amount plus any accrued and unpaid interest.
(3)
During July and August 2019, we repurchased a total of $39.4 million of our 8.375% Senior secured notes in the open market for a price of $34.3 million. We recognized a gain of $5.1 million on these repurchases which is reported in Gain on repurchases of senior secured notes in the consolidated statement of operations.
Schedule of Assets Held as Collateral Related to Secured Borrowings
Our assets held as collateral related to secured borrowings, committed under sale or other contractual obligations and which may be subject to secured liens under the SSTL and Senior Secured Notes are as follows at December 31, 2019:
 
 
 
Collateral for Secured Borrowings
 
 
 
 
 
Total Assets
 
Match Funded Liabilities
 
Financing Liabilities
 
Mortgage Loan Warehouse/MSR Facilities
 
Sales and Other Commitments (1)
 
Other (2)
Cash
$
428,339

 
$

 
$

 
$

 
$

 
$
428,339

Restricted cash
64,001

 
17,332

 

 
5,944

 
40,725

 

MSRs (3)
1,486,395

 

 
915,148

 
575,471

 

 
525

Advances, net
254,533

 

 

 

 
28,737

 
225,796

Match funded assets
801,990

 
801,990

 

 

 

 

Loans held for sale
275,269

 

 

 
236,517

 

 
38,752

Loans held for investment
6,292,938

 

 
6,144,275

 
115,130

 

 
33,533

Receivables, net
201,220

 

 

 
24,795

 

 
176,425

Premises and equipment, net
38,274

 

 

 

 

 
38,274

Other assets
563,240

 

 

 
5,285

 
510,236

 
47,719

Total Assets
$
10,406,199

 
$
819,322

 
$
7,059,423

 
$
963,142

 
$
579,698

 
$
989,363

(1)
Sales and Other Commitments include MSRs and related advances committed under sale agreements, Restricted cash and deposits held as collateral to support certain contractual obligations, and Contingent loan repurchase assets related to the Ginnie Mae EBO program for which a corresponding liability is recognized in Other liabilities.
(2)
The borrowings under the SSTL are secured by a first priority security interest in substantially all of the assets of Ocwen, PHH, PMC and the other guarantors thereunder, excluding among other things, 35% of the voting capital stock of foreign subsidiaries, securitization assets and equity interests of securitization entities, assets securing permitted funding indebtedness and non-recourse indebtedness, REO assets, as well as other customary carve-outs (collectively, the Collateral). The Collateral is subject to certain permitted liens set forth under the SSTL and related security agreement. The Senior Secured Notes are guaranteed by Ocwen and the other guarantors that guarantee the SSTL, and the borrowings under the Senior Secured Notes are secured by a second priority security interest in the Collateral. Assets securing borrowings under the SSTL and Senior Secured Notes may include amounts presented in Other as well as certain assets presented in Collateral for Secured Borrowings and Sales and Other Commitments, subject to permitted liens as defined in the applicable debt documents. The amounts presented here may differ in their calculation and are not intended to represent amounts that may be used in connection with covenants under the applicable debt documents.
(3)
MSRs pledged as collateral for secured borrowings includes MSRs pledged to NRZ in connection with the Rights to MSRs transactions which are accounted for as secured financings and MSRs securing the financing facilities. Certain MSR cohorts with a negative fair value of $4.7 million that would be presented as Other are excluded from the eligible collateral of the facilities and are comprised of $27.9 million of negative fair value related to RMBS and $23.2 million of positive fair value related to private EBO and PLS MSRs.
Schedule of Aggregate Long-term Borrowings
Certain of our borrowings mature within one year of the date of issuance of these financial statements. Based on management’s evaluation, we expect to renew, replace or extend all such borrowings to the extent necessary to finance our business on or prior to their respective maturities consistent with our historical experience.
 
Expected Maturity Date (1) (2) (3)
 
 
 
 
 
2020
 
2021
 
2022
 
2023
 
2024
 
Thereafter
 
Total
Balance
 
Fair
Value
Match funded liabilities
$
394,109

 
$
285,000

 
$

 
$

 
$

 
$

 
$
679,109

 
$
679,507

Other secured borrowings
832,078

 
98,971

 
41,663

 

 

 
57,594

 
1,030,306

 
1,010,789

Senior notes

 
21,543

 
291,509

 

 

 

 
313,052

 
270,022

 
$
1,226,187

 
$
405,514

 
$
333,172

 
$

 
$

 
$
57,594

 
$
2,022,467

 
$
1,960,318

(1)
Amounts are exclusive of any related discount, unamortized debt issuance costs or fair value adjustment.
(2)
For match funded liabilities, the Expected Maturity Date is the date on which the revolving period ends for each advance financing facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
(3)
Excludes financing liabilities recognized in connection with asset sales transactions accounted for as financings, including $1.0 billion recorded in connection with sales of Rights to MSRs and MSRs and $6.1 billion recorded in connection with the securitizations of HMBS. These financing liabilities have no contractual maturity and are amortized over the life of the underlying assets.
8.375% Senior Secured Notes Due In 2022  
Debt Instrument, Redemption [Line Items]  
Schedule of Redemption Prices
The redemption prices during the twelve-month periods beginning on November 15th of each year are as follows:
Year
 
Redemption Price
2018
 
106.281
%
2019
 
104.188

2020
 
102.094

2021 and thereafter
 
100.000